close
MENU
How to guide
How to guide
Home
The NBR Rich List
NBR Marketplace
NBR Video

Categories

General Business Investment Economics Te Ao Māori Politics Infrastructure Australia Tech & Innovation Finance Law Professional Services Primary Industries Retail Property Deals Marketing & Media Tourism Energy Luxury Property Aviation News Comings & Goings

Analysis

All Economy Matters Edwards on Politics Hunter’s Corner Last Word Margin Call On the Money Shoeshine Underarm NBR Focus

Featured

The NBR Rich List NBR Video Toil & Trouble Politically Speaking Morning Brew Dollars & Sense Startup Stars The Grind Market Outlook Executive Health Market Review Students’ Say The NBR Podcast Opinion (Archive) NBR Radar (Archive) Local Edge Private Bin NZ Aviation News (Archive) NBR Rich List (Archive) Your Business Audio Articles NBR Marketplace
Latest
Related
General Business
1

Medicinal cannabis firm Helius in voluntary administration
General Business
3

Noteholders seize control as Cannasouth tips into receivership
Primary Industries

Green Leaf-owned Cannabis Clinic pulls out of merger with Helius
Shoeshine
3

Winners and losers in NZ’s medicinal cannabis market
Investment
2

Listed medicinal cannabis firm Greenfern in receivership
Shoeshine
9

Housing projects face winter of discontent

ANALYSIS: Lack of presales, reluctant funders, construction challenges leading to world of pain for small-scale residential developers.

Maria Slade Mon, 17 Oct 2022
Shoeshine
1

Sure to rise: can new My Food Bag CEO deliver?

ANALYSIS: Kevin Bowler’s unexpected resignation as CEO last month gives much-maligned company a golden opportunity.

Hamish McNicol Mon, 10 Oct 2022
Shoeshine
5

Is Southern Cross squeezing the lemon too hard on fees?

ANALYSIS: One medical provider speaks out; Southern Cross says it’s no bully.

Fiona Rotherham Mon, 03 Oct 2022
Shoeshine
2

Supermarkets benevolently swallow the cost of inflation

ANALYSIS: Or do they? Supermarkets and suppliers locked in battle of wits.

Dita De Boni Tue, 27 Sep 2022
Shoeshine
3

Homegrown pharmaceutical firm takes long view

ANALYSIS: Let Douglas Pharmaceuticals not be an outlier in New Zealand’s promising health tech sector.

Maria Slade Mon, 19 Sep 2022
Shoeshine

Earnings season beats expectations but worst is yet to come

ANALYSIS: Headwinds as strong as ever despite listed companies reporting generally positive financial results.

Hamish McNicol Mon, 12 Sep 2022
Shoeshine

The new broom at global health IT provider Orion Health

ANALYSIS: ‘As I say to them, don’t mess it up,’ says founder and former CEO Ian McCrae.

Fiona Rotherham Mon, 05 Sep 2022
Shoeshine

Who are the Edmund Hillary Fellows?

Scheme to boost New Zealand’s entrepreneurial vitality welcomes latest cohort of recruits.

Will Mace Mon, 29 Aug 2022
Shoeshine
5

Another one gets away from the NZX

Partners Life's massive $1b sale should be celebrated, but has left some wondering what could have been.

Hamish McNicol Mon, 22 Aug 2022
1 17 18 19 20 21 59
Most Popular
Most Commented
Shoeshine

The second wave for NZ’s medicinal cannabis industry
Toil & Trouble

Employers and the fuel crisis: don’t panic, plan
The NBR Podcast

Podcast #98: NZ small businesses ‘lack ambition’
Margin Call

The importance of beholding earnings (expectations)
Dollars & Sense

Middle East war shocks fragile New Zealand economy
Market Review

War breeds market volatility as business confidence ‘smashed’
General Business
11

Racing industry warns of unsustainable ‘loops of decay’
Politically Speaking
7

Dealing with the fuel crisis and reshuffling the Cabinet
Hunter’s Corner
7

KMD Brands delivers an epic fail
Politics
7

‘Poor policy’: Retirement Commissioner slams KiwiSaver farm tweak
Investment
6

KMD launches deeply discounted $65.3m raise; chair to step down
Te Ao Māori
5

Pounamu court case exposes flaws in the law
Subscribe Login